![\"\"](\"https:\/\/www.purdue.edu\/newsroom\/wp-content\/uploads\/2025\/05\/PurdueLilly-WTagLockuponBlack-1024x479.jpg\" "\\"\\"")
<\/figure>\n<\/div>\n\n\nThe Lilly-Purdue 360 Initiative aims to achieve several key goals, including discovering and accelerating the delivery of medicines to patients; bridging the gap between laboratory discoveries and clinical applications; creating more resilient, efficient and sustainable supply chains; and deploying innovative, scalable approaches to workforce development. The expanded collaboration is also expected to generate significant economic benefits for Indiana by creating a highly skilled workforce and fostering local innovation. <\/p>\n\n\n\n
The earlier agreement, which had been set to expire in 2027, will now extend with four new projects added through 2032. Additionally, it will engage existing joint programs, such as Lilly Scholars at Purdue and the Lilly and Purdue Research Alliance Center (LPRC). Purdue will make space available for Lilly researchers on-site in West Lafayette. Purdue researchers will collaborate in Lilly facilities in Indianapolis and in Indiana’s LEAP Research and Innovation District.<\/p>\n\n\n\n \u201cAs potentially the largest single university-industry research agreement in American history, Lilly and Purdue are blazing a new trail to the endless frontier,\u201d said Purdue University President Mung Chiang. \u201cAs for our state, when its largest company and the largest university expand collaboration at a scale never seen before, especially in the backdrop of Lilly\u2019s manufacturing facility in LEAP, today marks a monumental watershed in the generation of jobs, workforce and innovation along America\u2019s Hard Tech Corridor. We thank Lilly for its pioneering impact on health and medicine in our society and for what is now the largest single research funding, from public or private capital, in Purdue\u2019s history.\u201d <\/p>\n\n\n\n To achieve the initiative\u2019s ambitious goals, Lilly and Purdue will concentrate on several key areas:<\/p>\n\n\n\n \u201cAccelerating the delivery of life-changing medicines demands a highly skilled workforce and continuous innovation across discovery, process development and manufacturing,\u201d said David A. Ricks, Lilly\u2019s chair and CEO. \u201cThrough this expanded collaboration with Purdue, we look forward to combining our strengths in advanced technologies and cutting-edge science to pioneer new methods of delivering next-generation medicines to advance human health.\u201d<\/p>\n\n\n\n The Lilly-Purdue 360 Initiative supports Purdue\u2019s One Health initiative<\/a>, which advances knowledge and innovation related to animal, human and plant well-being through novel interdisciplinary initiatives and partnerships with industry.<\/p>\n\n\n\n Purdue University is a public research university leading with excellence at scale. Ranked among top 10 public universities in the United States, Purdue discovers, disseminates and deploys knowledge with a quality and at a scale second to none. More than 107,000 students<\/a> study at Purdue across multiple campuses, locations and modalities, including more than 58,000 at our main campus in West Lafayette and Indianapolis. Committed to affordability and accessibility, Purdue\u2019s main campus has frozen tuition<\/a> 14 years in a row. See how Purdue never stops in the persistent pursuit of the next giant leap \u2014 including its comprehensive urban expansion, the Mitch Daniels School of Business, Purdue Computes and the One Health initiative \u2014 at https:\/\/www.purdue.edu\/president\/strategic-initiatives<\/a>.<\/p>\n\n\n\n Lilly is a medicine company turning science into healing to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150<\/a> years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer’s disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com<\/a> and Lilly.com\/news<\/a>, or follow us on Facebook<\/a>, Instagram<\/a>, and LinkedIn<\/a>.<\/p>\n\n\n![\"\"](\"https:\/\/www.purdue.edu\/newsroom\/wp-content\/uploads\/2025\/05\/LillywithScholars.jpg\" "\\"\\"")
\n
About Purdue University<\/h2>\n\n\n\n
About Lilly<\/h2>\n\n\n\n